UNSPSC 51182110: Desmopressin acetate trihydrate

This classification denotes an antidiurectic hormone analogue with the molecular formula C46H64N14O12S2.C2H4O2.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XB13HYU18U, chemically known as vasopressin, 1-(3-mercaptopropanoic acid)-8-d-arginine-, monoacetate (salt), trihydrate, but more generally known as desmopressin acetate trihydrate, which bears US NIH Compound Identifier 64759.

UNSPSC 51182110 Desmopressin acetate trihydrate is a Commodity code covering a synthetic vasopressin analog used to treat diabetes insipidus, nocturnal enuresis, and hemophilia A, procured by state and local health agencies, departments of corrections, and school districts for clinical and institutional use. State and local governments buy this pharmaceutical under the code as a prescription medication dispensed through institutional pharmacies, correctional health services, and school nurse programs; the drug is available in multiple formulations including intranasal spray, oral tablet, and injection, with procurement driven by patient population size and clinical protocols at each issuing body.

The source contains no recent state or local contract opportunities tagged to this code. Without posted solicitations, geographic concentration and issuing-body patterns cannot be characterized from current procurement activity.